PharmaTher Holdings Ltd (TSE:PHRM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PharmaTher Holdings Ltd. announced they have canceled a planned meeting with the FDA after receiving satisfactory preliminary responses regarding their Ketamine product’s application. The company is addressing minor deficiencies noted by the FDA and plans to resubmit necessary information by January 2025.
For further insights into TSE:PHRM stock, check out TipRanks’ Stock Analysis page.
